ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
71,080.71
0.45%
S&P 500
5,352.96
-0.02%
Dow Jones
38,886.17
0.20%
US Dollar vs Yen
155.3835
-0.21%
Brent Oil
79.525
-0.44%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Ginkgo Bioworks Holdings Inc (DNA)

  7. Ginkgo Bioworks Holdings Inc (DNA) ニュース

DNA

Ginkgo Bioworks (DNA)

Ginkgo Bioworks Holdings Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:DNA
日付受信時刻ニュースソース見出しコード企業名
2024/06/0623 : 03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0606 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0606 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0523 : 25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0423 : 08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0404 : 39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0403 : 08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/06/0100 : 39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/3023 : 58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2923 : 45Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2823 : 18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2423 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2323 : 02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2222 : 44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2200 : 02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2023 : 43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/2013 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1805 : 50Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1723 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1723 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1723 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1623 : 31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1602 : 24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1520 : 01PR Newswire (US)Ginkgo Bioworks to Participate in Two Conferences in MayNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1507 : 00PR Newswire (US)Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in JapanNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1423 : 48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1405 : 14Edgar (US Regulatory)Form 8-K - Current reportNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1405 : 05PR Newswire (US)Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSENYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1323 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
2024/05/1023 : 10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DNAGinkgo Bioworks Holdings Inc
 Showing the most relevant articles for your search:NYSE:DNA

最近閲覧した銘柄

NYSE
MCD
McDonalds
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
CCOM
US30
US 30
NYSE
JPM
JP Morgan Chase
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
FX
USDEUR
US Dollar vs Euro
USOTC
BASFY
BASF (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有